Cargando…
Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells
Food allergy affects an estimated 8% of children in the United States. Oral immunotherapy (OIT) is a recently approved treatment, with outcomes ranging from sustained tolerance to food allergens to no apparent benefit. The immunological underpinnings that influence clinical outcomes of OIT remain la...
Autores principales: | Monian, Brinda, Tu, Ang A., Ruiter, Bert, Morgan, Duncan M., Petrossian, Patrick M., Smith, Neal P., Gierahn, Todd M., Ginder, Julia H., Shreffler, Wayne G., Love, J. Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759778/ https://www.ncbi.nlm.nih.gov/pubmed/34813505 http://dx.doi.org/10.1172/JCI150634 |
Ejemplares similares
-
Identification of antigen-specific TCR sequences based on biological and statistical enrichment in unselected individuals
por: Smith, Neal P., et al.
Publicado: (2021) -
Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities
por: Davis, Carla M., et al.
Publicado: (2022) -
Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy
por: LaHood, Nicole A., et al.
Publicado: (2023) -
Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014) -
Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)